10x Genomics, Inc. (NASDAQ:TXG) Q1 2022 Earnings Conference Call May 4, 2022 4:30 PM ET

Company Participants

Cassie Corneau - Investor Relations and Strategic Finance

Serge Saxonov - Chief Executive Officer & Co-founder

Justin McAnear - Chief Financial Officer

Conference Call Participants

Tejas Savant - Morgan Stanley

Dan Brennan - Cohen

Mike Ryskin - Bank of America

Julia Qin - JPMorgan

Patrick Donnelly - Citi

Matt Larew - William Blair

Matt Sykes - Goldman Sachs

Operator

Hello and welcome to the 10x Genomics First Quarter 2022 Earnings Conference Call. My name is Katie and I'll be coordinating your call today. [Operator Instructions]. I will now hand over to your host, Cassie Corneau, Investor Relations and Strategic Finance to begin. Cassie please go ahead.

Cassie Corneau

Thank you and good afternoon, everyone. Earlier today, 10x Genomics released financial results for the first quarter ended March 31, 2022. If you have not received this news release or if you would like to be added to the company's distribution list, please send an e-mail to investors@10xgenomics.com. An archived webcast of this call will be available on the Investor tab of the company's website 10xgenomics.com for at least 45 days following this call.

Before we begin, I'd like to remind you that management will make statements during this call that are forward-looking statements within the meaning of federal securities laws. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated and you should not place undue reliance on forward-looking statements. Additional information regarding these risks, uncertainties and factors that could cause results to differ appears in the press release 10x Genomics issued today and in the documents and reports filed by 10x Genomics from time to time with the Securities and Exchange Commission.

10x Genomics disclaims any intention or obligation to update or revise any financial projections or forward-looking statements, whether because of new information, future events or otherwise. Joining the call today are Serge Saxonov our CEO and Co-Founder; and Justin McAnear, our Chief Financial Officer.

With that I will now turn the call over to Serge.

Serge Saxonov

Thanks, Cassie. Good afternoon and thank you for joining us. On today's call I will start with an overview of our performance during the first quarter. Next I will discuss our progress and momentum with customers and share an update on our upcoming product launches, including more detail on Xenium and the exciting opportunities we have ahead across all three platforms. Then I will hand the call over to Justin for a more detailed look at our financials, business trends and our outlook for the rest of the year.